Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in TCRX — TScan Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23,150
-$135,649 QoQ
Shares Held
23,623
-85.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 60 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. TCRX ranks #311 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in TCRX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,150 23,623
2026-03-31 $158,799 157,228
2025-12-31 $216,133 216,133
2025-09-30 $145,163 79,760
2025-06-30 $209,339 144,372
2025-03-31 $67,072 48,603
2024-12-31 $78,538 25,835
2024-09-30 $50,676 10,176
2024-03-31 $2,365,341 297,902
2023-12-31 $606,016 103,948
2023-09-30 $43,302 16,915